nodes	percent_of_prediction	percent_of_DWPC	metapath
Loteprednol—NR3C1—obesity	0.893	1	CbGaD
Loteprednol—NR3C1—Transcription factor regulation in adipogenesis—LPIN1—obesity	0.00219	0.0229	CbGpPWpGaD
Loteprednol—NR3C1—FOXA2 and FOXA3 transcription factor networks—HMGCS1—obesity	0.00193	0.0202	CbGpPWpGaD
Loteprednol—NR3C1—FOXA2 and FOXA3 transcription factor networks—ACADM—obesity	0.00187	0.0196	CbGpPWpGaD
Loteprednol—NR3C1—Nuclear Receptors—PPARD—obesity	0.00186	0.0195	CbGpPWpGaD
Loteprednol—NR3C1—Nuclear Receptors—NR1I3—obesity	0.0017	0.0178	CbGpPWpGaD
Loteprednol—NR3C1—AP-1 transcription factor network—MAF—obesity	0.00162	0.0169	CbGpPWpGaD
Loteprednol—NR3C1—Nuclear Receptors—NR1I2—obesity	0.00155	0.0163	CbGpPWpGaD
Loteprednol—NR3C1—FOXA2 and FOXA3 transcription factor networks—UCP2—obesity	0.00151	0.0158	CbGpPWpGaD
Loteprednol—NR3C1—Nuclear Receptor transcription pathway—PPARD—obesity	0.00147	0.0154	CbGpPWpGaD
Loteprednol—NR3C1—Transcription factor regulation in adipogenesis—ADIPOQ—obesity	0.00146	0.0153	CbGpPWpGaD
Loteprednol—NR3C1—FOXA2 and FOXA3 transcription factor networks—HADH—obesity	0.00142	0.0149	CbGpPWpGaD
Loteprednol—NR3C1—FOXA2 and FOXA3 transcription factor networks—PCK1—obesity	0.00142	0.0149	CbGpPWpGaD
Loteprednol—NR3C1—Transcription factor regulation in adipogenesis—SLC2A4—obesity	0.00138	0.0145	CbGpPWpGaD
Loteprednol—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—CLOCK—obesity	0.00135	0.0141	CbGpPWpGaD
Loteprednol—NR3C1—Nuclear Receptor transcription pathway—NR0B2—obesity	0.00134	0.014	CbGpPWpGaD
Loteprednol—NR3C1—Nuclear Receptor transcription pathway—NR1I3—obesity	0.00134	0.014	CbGpPWpGaD
Loteprednol—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—GNAS—obesity	0.0013	0.0136	CbGpPWpGaD
Loteprednol—NR3C1—Nuclear Receptor transcription pathway—NR1I2—obesity	0.00123	0.0128	CbGpPWpGaD
Loteprednol—NR3C1—Transcription factor regulation in adipogenesis—PPARGC1A—obesity	0.00119	0.0125	CbGpPWpGaD
Loteprednol—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—NAMPT—obesity	0.00118	0.0123	CbGpPWpGaD
Loteprednol—NR3C1—FOXA2 and FOXA3 transcription factor networks—IGFBP1—obesity	0.00117	0.0123	CbGpPWpGaD
Loteprednol—NR3C1—AP-1 transcription factor network—FABP4—obesity	0.0011	0.0115	CbGpPWpGaD
Loteprednol—Prednisone—HSD11B1—obesity	0.0011	0.094	CrCbGaD
Loteprednol—NR3C1—Transcription factor regulation in adipogenesis—FOXO1—obesity	0.00108	0.0113	CbGpPWpGaD
Loteprednol—NR3C1—FOXA2 and FOXA3 transcription factor networks—CPT1A—obesity	0.00105	0.011	CbGpPWpGaD
Loteprednol—NR3C1—Adipogenesis—PNPLA3—obesity	0.00104	0.0109	CbGpPWpGaD
Loteprednol—NR3C1—Adipogenesis—UCP1—obesity	0.00104	0.0109	CbGpPWpGaD
Loteprednol—NR3C1—FOXA2 and FOXA3 transcription factor networks—GCK—obesity	0.00102	0.0107	CbGpPWpGaD
Loteprednol—NR3C1—Circadian Clock—CLOCK—obesity	0.000982	0.0103	CbGpPWpGaD
Loteprednol—NR3C1—Adipogenesis—LIPE—obesity	0.000939	0.00984	CbGpPWpGaD
Loteprednol—NR3C1—FOXA2 and FOXA3 transcription factor networks—TFRC—obesity	0.000933	0.00977	CbGpPWpGaD
Loteprednol—NR3C1—Transcription factor regulation in adipogenesis—IRS2—obesity	0.000928	0.00972	CbGpPWpGaD
Loteprednol—NR3C1—Nuclear Receptors—ESR2—obesity	0.000923	0.00967	CbGpPWpGaD
Loteprednol—NR3C1—Glucocorticoid receptor regulatory network—NR1I3—obesity	0.000917	0.00961	CbGpPWpGaD
Loteprednol—NR3C1—Transcription factor regulation in adipogenesis—LEP—obesity	0.000908	0.00951	CbGpPWpGaD
Loteprednol—NR3C1—Adipogenesis—RETN—obesity	0.000901	0.00943	CbGpPWpGaD
Loteprednol—Ciclesonide—CES1—obesity	0.000882	0.0755	CrCbGaD
Loteprednol—NR3C1—Circadian Clock—CPT1A—obesity	0.000875	0.00917	CbGpPWpGaD
Loteprednol—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—NCOA1—obesity	0.000869	0.0091	CbGpPWpGaD
Loteprednol—NR3C1—Circadian Clock—NAMPT—obesity	0.000858	0.00899	CbGpPWpGaD
Loteprednol—NR3C1—Adipogenesis—GH1—obesity	0.000837	0.00877	CbGpPWpGaD
Loteprednol—NR3C1—Adipogenesis—CFD—obesity	0.000837	0.00877	CbGpPWpGaD
Loteprednol—NR3C1—Nuclear Receptors—AR—obesity	0.000816	0.00854	CbGpPWpGaD
Loteprednol—NR3C1—Transcription factor regulation in adipogenesis—IRS1—obesity	0.00081	0.00849	CbGpPWpGaD
Loteprednol—NR3C1—Transcription factor regulation in adipogenesis—PPARG—obesity	0.000791	0.00828	CbGpPWpGaD
Loteprednol—NR3C1—Adipogenesis—PLIN1—obesity	0.000787	0.00825	CbGpPWpGaD
Loteprednol—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—PPARGC1A—obesity	0.000785	0.00822	CbGpPWpGaD
Loteprednol—NR3C1—Adipogenesis—SCD—obesity	0.000766	0.00802	CbGpPWpGaD
Loteprednol—NR3C1—Circadian Clock—SREBF1—obesity	0.000765	0.00801	CbGpPWpGaD
Loteprednol—NR3C1—Regulation of nuclear SMAD2/3 signaling—MYOD1—obesity	0.000755	0.00791	CbGpPWpGaD
Loteprednol—NR3C1—Nuclear Receptor transcription pathway—ESR2—obesity	0.00073	0.00764	CbGpPWpGaD
Loteprednol—NR3C1—Adipogenesis—CYP26B1—obesity	0.000712	0.00746	CbGpPWpGaD
Loteprednol—NR3C1—Adipogenesis—PPARD—obesity	0.000697	0.0073	CbGpPWpGaD
Loteprednol—NR3C1—SIDS Susceptibility Pathways—ACADM—obesity	0.00068	0.00713	CbGpPWpGaD
Loteprednol—NR3C1—Regulation of Androgen receptor activity—NCOA1—obesity	0.000652	0.00683	CbGpPWpGaD
Loteprednol—NR3C1—SIDS Susceptibility Pathways—SLC9A3—obesity	0.000645	0.00676	CbGpPWpGaD
Loteprednol—NR3C1—Nuclear Receptor transcription pathway—AR—obesity	0.000644	0.00675	CbGpPWpGaD
Loteprednol—NR3C1—Circadian Clock—NCOA1—obesity	0.000633	0.00663	CbGpPWpGaD
Loteprednol—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—PPARA—obesity	0.000631	0.00661	CbGpPWpGaD
Loteprednol—NR3C1—Regulation of Androgen receptor activity—AR—obesity	0.000625	0.00655	CbGpPWpGaD
Loteprednol—NR3C1—Nuclear Receptors—PPARA—obesity	0.000618	0.00647	CbGpPWpGaD
Loteprednol—NR3C1—Adipogenesis—PCK1—obesity	0.000597	0.00625	CbGpPWpGaD
Loteprednol—NR3C1—Circadian Clock—PPARGC1A—obesity	0.000572	0.00599	CbGpPWpGaD
Loteprednol—NR3C1—Regulation of Androgen receptor activity—SIRT1—obesity	0.00057	0.00597	CbGpPWpGaD
Loteprednol—NR3C1—Nuclear Receptors—ESR1—obesity	0.00056	0.00586	CbGpPWpGaD
Loteprednol—NR3C1—Signaling events mediated by HDAC Class II—ESR1—obesity	0.00056	0.00586	CbGpPWpGaD
Loteprednol—NR3C1—AP-1 transcription factor network—TCF7L2—obesity	0.000556	0.00583	CbGpPWpGaD
Loteprednol—NR3C1—Regulation of Androgen receptor activity—FOXO1—obesity	0.000532	0.00558	CbGpPWpGaD
Loteprednol—NR3C1—SIDS Susceptibility Pathways—PPARGC1B—obesity	0.000531	0.00556	CbGpPWpGaD
Loteprednol—NR3C1—Transcription factor regulation in adipogenesis—MAPK8—obesity	0.000531	0.00556	CbGpPWpGaD
Loteprednol—NR3C1—Adipogenesis—LPIN1—obesity	0.000528	0.00553	CbGpPWpGaD
Loteprednol—NR3C1—FOXA2 and FOXA3 transcription factor networks—APOA1—obesity	0.000516	0.0054	CbGpPWpGaD
Loteprednol—NR3C1—Nuclear Receptors—PPARG—obesity	0.000511	0.00535	CbGpPWpGaD
Loteprednol—NR3C1—FOXA2 and FOXA3 transcription factor networks—F2—obesity	0.000492	0.00515	CbGpPWpGaD
Loteprednol—NR3C1—Nuclear Receptor transcription pathway—PPARA—obesity	0.000488	0.00512	CbGpPWpGaD
Loteprednol—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—SERPINE1—obesity	0.00047	0.00492	CbGpPWpGaD
Loteprednol—NR3C1—Regulation of nuclear SMAD2/3 signaling—NCOA1—obesity	0.000464	0.00486	CbGpPWpGaD
Loteprednol—NR3C1—Circadian Clock—PPARA—obesity	0.00046	0.00482	CbGpPWpGaD
Loteprednol—NR3C1—Glucocorticoid receptor regulatory network—PRL—obesity	0.00046	0.00482	CbGpPWpGaD
Loteprednol—NR3C1—Glucocorticoid receptor regulatory network—NCOA1—obesity	0.00046	0.00482	CbGpPWpGaD
Loteprednol—NR3C1—FOXA2 and FOXA3 transcription factor networks—INS—obesity	0.000446	0.00467	CbGpPWpGaD
Loteprednol—NR3C1—Regulation of nuclear SMAD2/3 signaling—AR—obesity	0.000445	0.00466	CbGpPWpGaD
Loteprednol—NR3C1—Nuclear Receptor transcription pathway—ESR1—obesity	0.000442	0.00463	CbGpPWpGaD
Loteprednol—NR3C1—Regulation of nuclear SMAD2/3 signaling—FOXO3—obesity	0.000442	0.00463	CbGpPWpGaD
Loteprednol—NR3C1—AP-1 transcription factor network—IL10—obesity	0.000437	0.00458	CbGpPWpGaD
Loteprednol—NR3C1—Adipogenesis—NAMPT—obesity	0.000431	0.00452	CbGpPWpGaD
Loteprednol—Exemestane—CYP19A1—obesity	0.000424	0.0363	CrCbGaD
Loteprednol—NR3C1—Transcription factor regulation in adipogenesis—TNF—obesity	0.00042	0.0044	CbGpPWpGaD
Loteprednol—NR3C1—FOXA2 and FOXA3 transcription factor networks—ALB—obesity	0.000409	0.00428	CbGpPWpGaD
Loteprednol—Testolactone—CYP19A1—obesity	0.000405	0.0346	CrCbGaD
Loteprednol—NR3C1—Nuclear Receptor transcription pathway—PPARG—obesity	0.000404	0.00423	CbGpPWpGaD
Loteprednol—NR3C1—SIDS Susceptibility Pathways—PRKAR2B—obesity	0.000394	0.00412	CbGpPWpGaD
Loteprednol—NR3C1—Regulation of nuclear SMAD2/3 signaling—IL10—obesity	0.000389	0.00408	CbGpPWpGaD
Loteprednol—NR3C1—Adipogenesis—SREBF1—obesity	0.000384	0.00403	CbGpPWpGaD
Loteprednol—NR3C1—SIDS Susceptibility Pathways—CPT1A—obesity	0.00038	0.00398	CbGpPWpGaD
Loteprednol—NR3C1—Regulation of nuclear SMAD2/3 signaling—FOXO1—obesity	0.000379	0.00397	CbGpPWpGaD
Loteprednol—NR3C1—SIDS Susceptibility Pathways—GCK—obesity	0.00037	0.00388	CbGpPWpGaD
Loteprednol—NR3C1—AP-1 transcription factor network—AGT—obesity	0.000367	0.00385	CbGpPWpGaD
Loteprednol—NR3C1—SIDS Susceptibility Pathways—TF—obesity	0.000353	0.0037	CbGpPWpGaD
Loteprednol—NR3C1—Adipogenesis—ADIPOQ—obesity	0.000353	0.0037	CbGpPWpGaD
Loteprednol—Testosterone Propionate—COMT—obesity	0.000352	0.0302	CrCbGaD
Loteprednol—NR3C1—AP-1 transcription factor network—ESR1—obesity	0.000343	0.0036	CbGpPWpGaD
Loteprednol—NR3C1—Circadian Clock—SERPINE1—obesity	0.000342	0.00359	CbGpPWpGaD
Loteprednol—NR3C1—Transcription factor regulation in adipogenesis—IL6—obesity	0.000339	0.00355	CbGpPWpGaD
Loteprednol—NR3C1—Adipogenesis—SLC2A4—obesity	0.000333	0.00349	CbGpPWpGaD
Loteprednol—NR3C1—SIDS Susceptibility Pathways—SLC6A4—obesity	0.000332	0.00348	CbGpPWpGaD
Loteprednol—Prednicarbate—NR3C1—obesity	0.000328	0.0281	CrCbGaD
Loteprednol—NR3C1—SIDS Susceptibility Pathways—NTRK2—obesity	0.000323	0.00339	CbGpPWpGaD
Loteprednol—NR3C1—Adipogenesis—NCOA1—obesity	0.000318	0.00333	CbGpPWpGaD
Loteprednol—Diflorasone—NR3C1—obesity	0.00031	0.0265	CrCbGaD
Loteprednol—Desonide—NR3C1—obesity	0.00031	0.0265	CrCbGaD
Loteprednol—NR3C1—Regulation of nuclear SMAD2/3 signaling—ESR1—obesity	0.000306	0.0032	CbGpPWpGaD
Loteprednol—Desoximetasone—NR3C1—obesity	0.000303	0.0259	CrCbGaD
Loteprednol—NR3C1—AP-1 transcription factor network—CCL2—obesity	0.000302	0.00317	CbGpPWpGaD
Loteprednol—NR3C1—SIDS Susceptibility Pathways—ESR2—obesity	0.000298	0.00312	CbGpPWpGaD
Loteprednol—NR3C1—Glucocorticoid receptor regulatory network—ICAM1—obesity	0.000298	0.00312	CbGpPWpGaD
Loteprednol—NR3C1—Adipogenesis—SOCS1—obesity	0.000297	0.00311	CbGpPWpGaD
Loteprednol—Fludrocortisone—AR—obesity	0.000295	0.0252	CrCbGaD
Loteprednol—NR3C1—Adipogenesis—SOCS3—obesity	0.000293	0.00307	CbGpPWpGaD
Loteprednol—NR3C1—Adipogenesis—PPARGC1A—obesity	0.000287	0.00301	CbGpPWpGaD
Loteprednol—Fluoxymesterone—SHBG—obesity	0.000278	0.0238	CrCbGaD
Loteprednol—Medrysone—NR3C1—obesity	0.000275	0.0235	CrCbGaD
Loteprednol—NR3C1—Glucocorticoid receptor regulatory network—POMC—obesity	0.000272	0.00285	CbGpPWpGaD
Loteprednol—NR3C1—AP-1 transcription factor network—CDKN2A—obesity	0.000264	0.00276	CbGpPWpGaD
Loteprednol—NR3C1—SIDS Susceptibility Pathways—AR—obesity	0.000263	0.00276	CbGpPWpGaD
Loteprednol—Testosterone Propionate—AR—obesity	0.000263	0.0225	CrCbGaD
Loteprednol—NR3C1—Regulation of Androgen receptor activity—MAPK8—obesity	0.000263	0.00275	CbGpPWpGaD
Loteprednol—NR3C1—Adipogenesis—LPL—obesity	0.000262	0.00274	CbGpPWpGaD
Loteprednol—NR3C1—Adipogenesis—FOXO1—obesity	0.00026	0.00272	CbGpPWpGaD
Loteprednol—NR3C1—AP-1 transcription factor network—IFNG—obesity	0.000257	0.00269	CbGpPWpGaD
Loteprednol—NR3C1—Gene Expression—APOBEC1—obesity	0.000256	0.00268	CbGpPWpGaD
Loteprednol—Hydrocortamate—NR3C1—obesity	0.000256	0.0219	CrCbGaD
Loteprednol—NR3C1—Generic Transcription Pathway—PPARD—obesity	0.000254	0.00266	CbGpPWpGaD
Loteprednol—Cortisone acetate—NR3C1—obesity	0.000252	0.0216	CrCbGaD
Loteprednol—NR3C1—Regulation of nuclear SMAD2/3 signaling—SERPINE1—obesity	0.000251	0.00263	CbGpPWpGaD
Loteprednol—NR3C1—SIDS Susceptibility Pathways—PPARGC1A—obesity	0.000248	0.0026	CbGpPWpGaD
Loteprednol—NR3C1—SIDS Susceptibility Pathways—GNB3—obesity	0.000248	0.0026	CbGpPWpGaD
Loteprednol—Fluoxymesterone—AR—obesity	0.000243	0.0208	CrCbGaD
Loteprednol—NR3C1—SIDS Susceptibility Pathways—BDNF—obesity	0.000241	0.00253	CbGpPWpGaD
Loteprednol—Amcinonide—NR3C1—obesity	0.000238	0.0204	CrCbGaD
Loteprednol—Budesonide—NR3C1—obesity	0.000238	0.0204	CrCbGaD
Loteprednol—NR3C1—Generic Transcription Pathway—NR1I3—obesity	0.000232	0.00243	CbGpPWpGaD
Loteprednol—NR3C1—Generic Transcription Pathway—NR0B2—obesity	0.000232	0.00243	CbGpPWpGaD
Loteprednol—NR3C1—Adipogenesis—PPARA—obesity	0.000231	0.00242	CbGpPWpGaD
Loteprednol—NR3C1—SIDS Susceptibility Pathways—IL10—obesity	0.00023	0.00241	CbGpPWpGaD
Loteprednol—Mometasone—NR3C1—obesity	0.000227	0.0194	CrCbGaD
Loteprednol—NR3C1—Glucocorticoid receptor regulatory network—IFNG—obesity	0.000227	0.00237	CbGpPWpGaD
Loteprednol—Methyltestosterone—SHBG—obesity	0.000224	0.0192	CrCbGaD
Loteprednol—NR3C1—Adipogenesis—IRS2—obesity	0.000224	0.00235	CbGpPWpGaD
Loteprednol—Rimexolone—NR3C1—obesity	0.000224	0.0192	CrCbGaD
Loteprednol—NR3C1—Adipogenesis—AGT—obesity	0.000224	0.00234	CbGpPWpGaD
Loteprednol—NR3C1—Adipogenesis—LEP—obesity	0.000219	0.0023	CbGpPWpGaD
Loteprednol—NR3C1—AP-1 transcription factor network—MMP9—obesity	0.000216	0.00226	CbGpPWpGaD
Loteprednol—NR3C1—Generic Transcription Pathway—NR1I2—obesity	0.000212	0.00222	CbGpPWpGaD
Loteprednol—Beclomethasone—NR3C1—obesity	0.000211	0.0181	CrCbGaD
Loteprednol—Alclometasone—NR3C1—obesity	0.000205	0.0176	CrCbGaD
Loteprednol—NR3C1—SIDS Susceptibility Pathways—HTR2A—obesity	0.000204	0.00213	CbGpPWpGaD
Loteprednol—Fludrocortisone—NR3C1—obesity	0.0002	0.0171	CrCbGaD
Loteprednol—Clobetasol propionate—NR3C1—obesity	0.0002	0.0171	CrCbGaD
Loteprednol—Flunisolide—NR3C1—obesity	0.0002	0.0171	CrCbGaD
Loteprednol—Paramethasone—NR3C1—obesity	0.000197	0.0169	CrCbGaD
Loteprednol—Methyltestosterone—AR—obesity	0.000197	0.0168	CrCbGaD
Loteprednol—NR3C1—Adipogenesis—IRS1—obesity	0.000196	0.00205	CbGpPWpGaD
Loteprednol—NR3C1—Gene Expression—CTNNBL1—obesity	0.000194	0.00203	CbGpPWpGaD
Loteprednol—Ciclesonide—NR3C1—obesity	0.000194	0.0166	CrCbGaD
Loteprednol—Triamcinolone—BCHE—obesity	0.000193	0.0166	CrCbGaD
Loteprednol—Fluorometholone—NR3C1—obesity	0.000193	0.0165	CrCbGaD
Loteprednol—NR3C1—Adipogenesis—PPARG—obesity	0.000191	0.002	CbGpPWpGaD
Loteprednol—Fluoxymesterone—ESR1—obesity	0.000188	0.016	CrCbGaD
Loteprednol—NR3C1—Adipogenesis—INS—obesity	0.000187	0.00196	CbGpPWpGaD
Loteprednol—Methylprednisolone—NR3C1—obesity	0.000186	0.0159	CrCbGaD
Loteprednol—NR3C1—Glucocorticoid receptor regulatory network—MAPK8—obesity	0.000185	0.00194	CbGpPWpGaD
Loteprednol—NR3C1—Endoderm Differentiation—TGFB1—obesity	0.000182	0.00191	CbGpPWpGaD
Loteprednol—NR3C1—Adipogenesis—IGF1—obesity	0.000181	0.0019	CbGpPWpGaD
Loteprednol—NR3C1—FOXA2 and FOXA3 transcription factor networks—AKT1—obesity	0.00018	0.00188	CbGpPWpGaD
Loteprednol—NR3C1—AP-1 transcription factor network—MYC—obesity	0.000179	0.00187	CbGpPWpGaD
Loteprednol—NR3C1—AP-1 transcription factor network—TGFB1—obesity	0.000178	0.00187	CbGpPWpGaD
Loteprednol—NR3C1—Adipogenesis—SERPINE1—obesity	0.000172	0.0018	CbGpPWpGaD
Loteprednol—Hydrocortisone—SHBG—obesity	0.000169	0.0145	CrCbGaD
Loteprednol—Fluoxymesterone—NR3C1—obesity	0.000165	0.0141	CrCbGaD
Loteprednol—Methyltestosterone—CYP19A1—obesity	0.000165	0.0141	CrCbGaD
Loteprednol—NR3C1—Regulation of nuclear SMAD2/3 signaling—MYC—obesity	0.000159	0.00166	CbGpPWpGaD
Loteprednol—Betamethasone—CYP19A1—obesity	0.000159	0.0136	CrCbGaD
Loteprednol—Triamcinolone—NR3C1—obesity	0.000157	0.0134	CrCbGaD
Loteprednol—Prednisone—NR3C1—obesity	0.000142	0.0122	CrCbGaD
Loteprednol—NR3C1—AP-1 transcription factor network—IL6—obesity	0.000134	0.00141	CbGpPWpGaD
Loteprednol—NR3C1—Generic Transcription Pathway—PARP1—obesity	0.000133	0.00139	CbGpPWpGaD
Loteprednol—Prednisolone—NR3C1—obesity	0.000131	0.0112	CrCbGaD
Loteprednol—Betamethasone—NR3C1—obesity	0.000129	0.011	CrCbGaD
Loteprednol—NR3C1—Generic Transcription Pathway—ESR2—obesity	0.000126	0.00132	CbGpPWpGaD
Loteprednol—NR3C1—Gene Expression—PPARD—obesity	0.000122	0.00128	CbGpPWpGaD
Loteprednol—NR3C1—SIDS Susceptibility Pathways—IL1B—obesity	0.000121	0.00127	CbGpPWpGaD
Loteprednol—NR3C1—Glucocorticoid receptor regulatory network—IL6—obesity	0.000118	0.00124	CbGpPWpGaD
Loteprednol—NR3C1—Adipogenesis—STAT3—obesity	0.000117	0.00123	CbGpPWpGaD
Loteprednol—NR3C1—Generic Transcription Pathway—NCOA1—obesity	0.000116	0.00122	CbGpPWpGaD
Loteprednol—NR3C1—Gene Expression—NR1I3—obesity	0.000112	0.00117	CbGpPWpGaD
Loteprednol—NR3C1—Gene Expression—NR0B2—obesity	0.000112	0.00117	CbGpPWpGaD
Loteprednol—NR3C1—Generic Transcription Pathway—AR—obesity	0.000111	0.00117	CbGpPWpGaD
Loteprednol—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—obesity	0.00011	0.00115	CbGpPWpGaD
Loteprednol—NR3C1—Glucocorticoid receptor regulatory network—AKT1—obesity	0.000109	0.00114	CbGpPWpGaD
Loteprednol—NR3C1—Adipogenesis—TGFB1—obesity	0.000109	0.00114	CbGpPWpGaD
Loteprednol—NR3C1—Gene Expression—NR1I2—obesity	0.000102	0.00107	CbGpPWpGaD
Loteprednol—NR3C1—Adipogenesis—TNF—obesity	0.000101	0.00106	CbGpPWpGaD
Loteprednol—Hydrocortisone—NR3C1—obesity	0.0001	0.00859	CrCbGaD
Loteprednol—Dexamethasone—CYP19A1—obesity	9.24e-05	0.0079	CrCbGaD
Loteprednol—Triamcinolone—PTGS2—obesity	8.91e-05	0.00763	CrCbGaD
Loteprednol—NR3C1—SIDS Susceptibility Pathways—TNF—obesity	8.77e-05	0.000918	CbGpPWpGaD
Loteprednol—NR3C1—Generic Transcription Pathway—PPARA—obesity	8.44e-05	0.000884	CbGpPWpGaD
Loteprednol—NR3C1—Adipogenesis—IL6—obesity	8.18e-05	0.000857	CbGpPWpGaD
Loteprednol—NR3C1—Generic Transcription Pathway—ESR1—obesity	7.64e-05	0.000801	CbGpPWpGaD
Loteprednol—Dexamethasone—NR3C1—obesity	7.48e-05	0.0064	CrCbGaD
Loteprednol—Betamethasone—PTGS2—obesity	7.3e-05	0.00625	CrCbGaD
Loteprednol—Prednisone—ALB—obesity	7.2e-05	0.00616	CrCbGaD
Loteprednol—NR3C1—SIDS Susceptibility Pathways—IL6—obesity	7.07e-05	0.000741	CbGpPWpGaD
Loteprednol—NR3C1—Generic Transcription Pathway—PPARG—obesity	6.97e-05	0.00073	CbGpPWpGaD
Loteprednol—Dexamethasone—CYP2E1—obesity	6.89e-05	0.00589	CrCbGaD
Loteprednol—Methyltestosterone—ALB—obesity	6.74e-05	0.00577	CrCbGaD
Loteprednol—NR3C1—Gene Expression—PARP1—obesity	6.41e-05	0.000671	CbGpPWpGaD
Loteprednol—NR3C1—Generic Transcription Pathway—SERPINE1—obesity	6.28e-05	0.000658	CbGpPWpGaD
Loteprednol—NR3C1—Gene Expression—ESR2—obesity	6.07e-05	0.000635	CbGpPWpGaD
Loteprednol—NR3C1—Gene Expression—NCOA1—obesity	5.59e-05	0.000586	CbGpPWpGaD
Loteprednol—NR3C1—Gene Expression—AR—obesity	5.36e-05	0.000561	CbGpPWpGaD
Loteprednol—NR3C1—Gene Expression—SIRT1—obesity	4.89e-05	0.000512	CbGpPWpGaD
Loteprednol—Dexamethasone—PTGS2—obesity	4.25e-05	0.00363	CrCbGaD
Loteprednol—NR3C1—Gene Expression—PRKCD—obesity	4.24e-05	0.000444	CbGpPWpGaD
Loteprednol—NR3C1—Gene Expression—PPARA—obesity	4.06e-05	0.000425	CbGpPWpGaD
Loteprednol—NR3C1—Generic Transcription Pathway—MYC—obesity	3.98e-05	0.000416	CbGpPWpGaD
Loteprednol—NR3C1—Gene Expression—ESR1—obesity	3.68e-05	0.000385	CbGpPWpGaD
Loteprednol—NR3C1—Gene Expression—PPARG—obesity	3.36e-05	0.000352	CbGpPWpGaD
Loteprednol—NR3C1—Gene Expression—SERPINE1—obesity	3.02e-05	0.000317	CbGpPWpGaD
Loteprednol—NR3C1—Gene Expression—MYC—obesity	1.91e-05	0.0002	CbGpPWpGaD
Loteprednol—NR3C1—Gene Expression—AKT1—obesity	1.33e-05	0.000139	CbGpPWpGaD
